Literature DB >> 8590813

Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.

B Trinczek1, J Biernat, K Baumann, E M Mandelkow, E Mandelkow.   

Abstract

The dynamic instability of microtubules is thought to be regulated by MAPs and phosphorylation. Here we describe the effect of the neuronal microtubule-associated protein tau by observing the dynamics of single microtubules by video microscopy. We used recombinant tau isoforms and tau mutants, and we phosphorylated tau by the neuronal kinases MARK (affecting the KXGS motifs within tau's repeat domain) and cdk5 (phosphorylating Ser-Pro motifs in the regions flanking the repeats). The variants of tau can be broadly classified into three categories, depending on their potency to affect microtubule dynamics. "Strong" tau variants have four repeats and both flanking regions. "Medium" variants have one to three repeats and both flanking regions. "Weak" variants lack one or both of the flanking regions, or have no repeats; with such constructs, microtubule dynamics is not significantly different from that of pure tubulin. N- or C-terminal tails of tau have no influence on dynamic instability. The two ends of microtubules (plus and minus) showed different activities but analogous behavior. These results are consistent with the "jaws" model of tau where the flanking regions are considered as targeting domains whereas the addition of repeats makes them catalytically active in terms of microtubule stabilization. The dominant changes in the parameters of dynamic instability induced by tau are those in the dissociation rate and in the catastrophe rate (up to 30-fold). Other rates change only moderately or not at all (association rate increased up to twofold, rates of rescue or rapid shrinkage decreased up to approximately twofold). The order of repeats has little influence on microtubule dynamics (i.e., repeats can be re-arranged or interchanged), arguing in favor of the "distributed weak binding" model proposed by Butner and Kirschner (1991); however, we confirmed the presence of a "hotspot" of binding potential involving Lys274 and Lys281 observed by Goode and Feinstein, 1994. Phosphorylation of Ser-Pro motifs by cdk5 (mainly Ser 202, 235, and 404) in the flanking regions had a moderate effect on microtubule dynamics while phosphorylation at the "Alzheimer"-site Ser262 MARK eliminated tau's interactions with microtubules. In both cases the predominant effects of phosphorylation are on the rates of tubulin dissociation and catastrophe whereas the effects on the rates of association or rescue are comparatively small.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590813      PMCID: PMC366657          DOI: 10.1091/mbc.6.12.1887

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  70 in total

1.  A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule.

Authors:  S Kobayashi; K Ishiguro; A Omori; M Takamatsu; M Arioka; K Imahori; T Uchida
Journal:  FEBS Lett       Date:  1993-12-06       Impact factor: 4.124

2.  Peptides from the conserved ends of the rod domain of desmin disassemble intermediate filaments and reveal unexpected structural features: a circular dichroism, Fourier transform infrared, and electron microscopic study.

Authors:  N Geisler; T Heimburg; J Schünemann; K Weber
Journal:  J Struct Biol       Date:  1993 May-Jun       Impact factor: 2.867

3.  Microtubule-associated protein 2 alters the dynamic properties of microtubule assembly and disassembly.

Authors:  R J Kowalski; R C Williams
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

Review 4.  Tau as a marker for Alzheimer's disease.

Authors:  E M Mandelkow; E Mandelkow
Journal:  Trends Biochem Sci       Date:  1993-12       Impact factor: 13.807

5.  Human tau isoforms confer distinct morphological and functional properties to stably transfected fibroblasts.

Authors:  M M Lo; A W Fieles; T E Norris; P G Dargis; C B Caputo; C W Scott; V M Lee; M Goedert
Journal:  Brain Res Mol Brain Res       Date:  1993-11

6.  Substrate specificity characterization of a cdc2-like protein kinase purified from bovine brain.

Authors:  K N Beaudette; J Lew; J H Wang
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

7.  Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding.

Authors:  J Biernat; N Gustke; G Drewes; E M Mandelkow; E Mandelkow
Journal:  Neuron       Date:  1993-07       Impact factor: 17.173

8.  Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau.

Authors:  H Yoshida; Y Ihara
Journal:  J Neurochem       Date:  1993-09       Impact factor: 5.372

9.  Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.

Authors:  H K Paudel; J Lew; Z Ali; J H Wang
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

10.  Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5.

Authors:  K Baumann; E M Mandelkow; J Biernat; H Piwnica-Worms; E Mandelkow
Journal:  FEBS Lett       Date:  1993-12-28       Impact factor: 4.124

View more
  116 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Tau protein function in axonal formation.

Authors:  G Paglini; L Peris; F Mascotti; S Quiroga; A Caceres
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

3.  ZipA is a MAP-Tau homolog and is essential for structural integrity of the cytokinetic FtsZ ring during bacterial cell division.

Authors:  D RayChaudhuri
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

4.  Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis.

Authors:  N Larsson; U Marklund; H M Gradin; G Brattsand; M Gullberg
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

5.  Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.

Authors:  Preeti J Khandelwal; Sonya B Dumanis; Alexander M Herman; G William Rebeck; Charbel E-H Moussa
Journal:  Mol Cell Neurosci       Date:  2011-09-14       Impact factor: 4.314

6.  Heterogeneous Tau-Tubulin Complexes Accelerate Microtubule Polymerization.

Authors:  Xiao-Han Li; Elizabeth Rhoades
Journal:  Biophys J       Date:  2017-06-20       Impact factor: 4.033

Review 7.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

8.  Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.

Authors:  Kristine Cox; Benjamin Combs; Brenda Abdelmesih; Gerardo Morfini; Scott T Brady; Nicholas M Kanaan
Journal:  Neurobiol Aging       Date:  2016-07-29       Impact factor: 4.673

9.  Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action.

Authors:  H Eric Feinstein; Sarah J Benbow; Nichole E LaPointe; Nirav Patel; Srinivasan Ramachandran; Thanh D Do; Michelle R Gaylord; Noelle E Huskey; Nicolette Dressler; Megan Korff; Brady Quon; Kristi Lazar Cantrell; Michael T Bowers; Ratnesh Lal; Stuart C Feinstein
Journal:  J Neurochem       Date:  2016-04-20       Impact factor: 5.372

10.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Authors:  P Rizzu; J C Van Swieten; M Joosse; M Hasegawa; M Stevens; A Tibben; M F Niermeijer; M Hillebrand; R Ravid; B A Oostra; M Goedert; C M van Duijn; P Heutink
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.